1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐ and 1‐Methyl‐4‐(2′‐Ethylphenyl)‐1,2,3,6‐Tetrahydropyridine‐Induced Toxicity in PC 12 Cells: Role of Monoamine Oxidase A

Journal of Neurochemistry

Volumn 55, Issue 3, 1990, Pages 870-877

  Basma, Alie N ^a   Heikkila, Richard E ^a   Nicklas, William J ^a   Giovanni, Andrew ^a   Geller, Herbert M ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Monoamine oxidase; PC12 cells; Pyridinium species; Tetrahydropyridines

Indexed keywords

GYMNOMYZA SAMOENSIS; MAMMALIA;

1,2,3,6 TETRAHYDRO 1 METHYL 4 (2 METHYLPHENYL)PYRIDINE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; UNCLASSIFIED DRUG;

ARTICLE; MAMMAL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ADRENAL GLAND NEOPLASMS; ANIMAL; CELL SURVIVAL; CLORGYLINE; KINETICS; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; OXIDATION-REDUCTION; PARGYLINE; PHEOCHROMOCYTOMA; PYRIDINIUM COMPOUNDS; RATS; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0025023850     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.1990.tb04572.x     Document Type: Article

References (43)

1. Effects of MPTP, 2′ethyl‐MPTP and their pyridinium species on cultured PC12 cells
2. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by iV‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
3. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase
4. Mesencephalic dopamine neurons become less sensitive to 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine toxicity during development in vitro
5. Chronic parkinsonism secondary to intravenous injection of meperidine analogues
6. A dopaminergic cell line variant resistant to the neurotoxin l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
7. Effects of l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF
8. Regulation of the differentiation of PC12 pheochromocytoma cells
9. Deprenyl antagonizes acute lethality of l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in mice
10. 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost
11. Release, storage and uptake of catecholamine by a clonal cell line of nerve growth factor (NGF) responsive pheochromocytoma cells
12. Dopaminergic neurotoxicity of 1‐methyl‐4‐phenyl‐1,2,5,6‐tetrahydropyridine in mice
13. Protection against the dopaminergic neurotoxicity of 1‐methyl‐4‐phenyl‐1,2,5,6‐tetrahydropyridine by monoamine oxidase inhibitors
14. Dopaminergic toxicity of rotenone and the l‐methyl‐4‐phenyl‐pyridinium ion after their stereotaxic administration to rats: implication for the mechanism of l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine toxicity
15. Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of l‐methyl‐4‐phenyl‐1,2,3,6‐letrahydropyridine
16. Parkinsonism‐inducing neurotoxin, N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine: uptake of the metabolite N‐methyl‐4‐phenylpyridine by dopamine neurons explains selective toxicity
17. An improved method to determine cell viability by simultaneous staining with fluorescein diacetatepropidium iodide
18. Role for monoamine oxidase‐A (MAO‐A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog. 2′Me‐MPTP
19. Rapid flow cytometric analysis of mammalian cell cycle by propidium iodide staining
20. Chronic parkinsonism in humans due to a product of meperidine‐analog synthesis
21. Pargyline prevents MPTP‐induced parkinsonism in primates
22. Intraneuronal generation of a pyri‐dinium metabolite may cause drug‐induced parkinsonism
23. + in PC12 pheochromocytoma cells: binding and biological studies
24. Prevention of the nigrostriatal toxicity of l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine by inhibitors of 3,4‐dihydroxyphenylethylamine transport
25. Metabolism of N‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in a rat pheochromocytoma cell line, PC12h
26. Inhibition of NADH‐linked oxidation in brain mitochondria by l‐methyl‐4‐phenyl‐pyridine, a metabolite of the neurotoxin, l‐methyl‐4‐phenyl‐1,2,5,6‐tetrahydropyridine
27. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease
28. Energy‐dependent uptake of N‐methyl‐4‐phenylpyridinium, the neurotoxic metabolite of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine, by mitochondria
29. Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idio‐pathic parkinsonism
30. Storage of dopamine and acetylcholine in granules of PC12, a clonal pheochromocytoma cell line
31. Cation‐exchange high‐performance liquid chromatography assay for the nigrostriatal toxicant l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine and its monoamine oxidase B generated metabolites in brain tissues
32. Storage and release of acetylcholine by a clonal cell line
33. +), the toxic bioactivation product of l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)
34. + by dopamine is required for MPTP toxicity: studies in brai n synaptosomes and PC 12 cells
35. Characteristics of l‐methyl‐4–(2′‐methylphenyl)‐1,2,3,6‐tetrahydropyridine‐induced neurotoxicity in the mouse
36. Studies on the effect of l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice
37. Studies on the neurotoxicity of l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine: inhibition of NAD‐linked substrate oxidation by its metabolite, l‐methyl‐4‐phenylpyridinium
38. Species differences in monoamine oxidase‐A and ‐B as revealed by sensitivity to trypsin
39. Contrasting monoamine oxidase activity and tyramine induced catecholamine release in PC12 cells and chromaffin cells
40. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine
41. Structure‐activity of the mechanism of l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs
42. Structure‐activity study of the mechanism of l‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monoamine oxidase‐catalyzed oxidation of MPTP analogs